High EZH2 Protein Expression Is a Poor Prognostic Predictor in IDH1 R132H-Negative Gliomas

Accumulating data indicates that enhancer of zeste homology 2 (EZH2) and isocitrate dehydrogenase 1 (IDH1) are implicated in promoting tumourigenesis in a myriad of malignancies including gliomas. We aimed to determine the immunoexpression of EZH2 in gliomas and its correlation with clinicopathologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Yin Ping, Che Abdul Aziz, Roziasyazni, Noor Aizuddin, Azimatun, Mohd Saleh, Muhamad Fakhri, Mohd Arshad, Roslina, Tan, Geok Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600772/
https://www.ncbi.nlm.nih.gov/pubmed/36292072
http://dx.doi.org/10.3390/diagnostics12102383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600772/
https://www.ncbi.nlm.nih.gov/pubmed/36292072
http://dx.doi.org/10.3390/diagnostics12102383

Ejemplares similares